Welcome to LookChem.com Sign In|Join Free

CAS

  • or

118-00-3

Post Buying Request

118-00-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

118-00-3 Usage

Description

Different sources of media describe the Description of 118-00-3 differently. You can refer to the following data:
1. Guanosine is a purine nucleoside, in which the guanine attached to the C1 carbon of a ribose (ribofuranose) ring via a β-N9-glycosidic bond. Its phosphorylated derivatives include GMP (guanosine monophosphate), cGMP (cyclic guanosine monophosphate), GDP (guanosine diphosphate), and GTP (guanosine triphosphate). These guanosine derivatives are very important in various biochemical processes, such as synthesis of nucleic acids and proteins, photosynthesis, muscle contraction, and intracellular signal transduction. Guanosine is thought to have neuroprotective properties. It can reduce neuroinflammation, oxidative stress, and excitotoxicity, as well as exerting trophic effects in neuronal and glial cells.?It is shown to be protective in central nervous system diseases including ischemic stroke, Alzheimer’s disease, Parkinson’s disease, spinal cord injury, nociception, and depression. Guanosine is found to be associated with purine nucleoside phosphorylase (PNP) deficiency, which is an inborn error of metabolism.
2. Guanosine is a purine nucleoside that is comprised of the purine base guanine attached to a ribose moiety. Mono-, di-, tri-, and cyclic monophosphorylated forms of guanosine (GMP, GDP, GTP, and cGMP, respectively) are essential for a variety of endogenous biochemical processes, such as signal transduction, metabolism, and RNA synthesis.

Reference

L. E. B. Bettio, J. Gil-Mohapel, A. L. S. Rodrigues, Guanosine and its role in neurophathologies, Purinergic Signal, 2016, vol. 12, pp. 411-426

Chemical Properties

White, crystalline powder; odorless; mild saline taste. Very slightly soluble in cold water; soluble in boiling water, dilute mineral acids, hot acetic acid, and dilute bases; insoluble in alcohol, ether, chloroform, and benzene.

Uses

Different sources of media describe the Uses of 118-00-3 differently. You can refer to the following data:
1. A constituent of nucleic acids.
2. Guanosine has been used:as a reference standard for the analysis of glucosinolates by high-performance liquid chromatography with diode-array detection and electrospray ionization tandem mass spectrometry (HPLC-DAD-ESI/MS)as a component of Mouse Embryonic Fibroblasts (MEFs) cultureas a standard for the detection of residual RNA contaminant in oil palm plant genome samples by HPLC
3. Guanosine is used as a constituent of nucleic acids. It is used in metallic paints, simulated pearls,plastics,cosmetics industry etc,. It has been also used in pharmacokinetics as a prodrug. Guanosine is used in cell culture applications as a precursor of GMP.

Definition

Different sources of media describe the Definition of 118-00-3 differently. You can refer to the following data:
1. A NUCLEOSIDE present in DNA and RNA and consisting of guanine linked to D-ribose via a β-glycosidic bond.
2. ChEBI: A purine nucleoside in which guanine is attached to ribofuranose via a beta-N9-glycosidic bond.

General Description

Guanosine is an aromatic organic molecule and a purine nucleoside. It is present in the cerebrospinal fluid, intestinal cells, blood-brain barrier and in brain microvessels.

Biochem/physiol Actions

Guanosine nucleoside elicits cellular effect as the guanine-based purinergic system. It modulates glutamate uptake by glutamate transporters. It may have neuroprotective functionality in central nervous system disorders. Guanosine promotes neurite arborization, outgrowth, proliferation and differentiation. Administration of guanosine replenished GTP and elicits protective function in renal ischemic injury.

Purification Methods

It crystallises from water as a dihydrate. Dry it at 110o.[Beilstein 26/18 V 81.]

Check Digit Verification of cas no

The CAS Registry Mumber 118-00-3 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 1,1 and 8 respectively; the second part has 2 digits, 0 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 118-00:
(5*1)+(4*1)+(3*8)+(2*0)+(1*0)=33
33 % 10 = 3
So 118-00-3 is a valid CAS Registry Number.
InChI:InChI=1/C10H13N5O5/c11-10-13-7-4(8(19)14-10)12-2-15(7)9-6(18)5(17)3(1-16)20-9/h2-3,5-6,9,16-18H,1H2,(H3,11,13,14,19)/t3-,5+,6-,9+/m1/s1

118-00-3 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (G0171)  Guanosine  >98.0%(HPLC)(T)

  • 118-00-3

  • 5g

  • 185.00CNY

  • Detail
  • TCI America

  • (G0171)  Guanosine  >98.0%(HPLC)(T)

  • 118-00-3

  • 25g

  • 445.00CNY

  • Detail
  • TCI America

  • (G0171)  Guanosine  >98.0%(HPLC)(T)

  • 118-00-3

  • 100g

  • 1,180.00CNY

  • Detail
  • Alfa Aesar

  • (A11328)  Guanosine, 98+%   

  • 118-00-3

  • 25g

  • 241.0CNY

  • Detail
  • Alfa Aesar

  • (A11328)  Guanosine, 98+%   

  • 118-00-3

  • 50g

  • 434.0CNY

  • Detail
  • Alfa Aesar

  • (A11328)  Guanosine, 98+%   

  • 118-00-3

  • 100g

  • 762.0CNY

  • Detail
  • Alfa Aesar

  • (A11328)  Guanosine, 98+%   

  • 118-00-3

  • 250g

  • 1763.0CNY

  • Detail

118-00-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name guanosine

1.2 Other means of identification

Product number -
Other names Guanosin

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:118-00-3 SDS

118-00-3Synthetic route

2-N-(N,N-dibenzylformamidino)-9-(2,3-O-benzylidene-β-D-ribofuranosyl)-guanine

2-N-(N,N-dibenzylformamidino)-9-(2,3-O-benzylidene-β-D-ribofuranosyl)-guanine

Conditions
ConditionsYield
With hydrogen; palladium on activated charcoal; palladium hydroxide - carbon In water; tert-butyl alcohol at 20℃; under 2068.59 Torr; for 20h; Hydrogenolysis;99%
2',3'-O-benzylidene-2N-dimethylaminomethylene guanosine

2',3'-O-benzylidene-2N-dimethylaminomethylene guanosine

Conditions
ConditionsYield
With hydrogen; palladium on activated charcoal; palladium hydroxide - carbon In water; tert-butyl alcohol at 20℃; under 2068.59 Torr; for 20h; Hydrogenolysis;98%
N-2-(ethoxycarbonyl)guanosine
100313-43-7

N-2-(ethoxycarbonyl)guanosine

Conditions
ConditionsYield
With pyridine; ammonium hydroxide at 45℃; for 48h;95%
9-(2',3'-di-O-acetyl-β-D-ribofuranosyl)-N2-isobutanoylguanine

9-(2',3'-di-O-acetyl-β-D-ribofuranosyl)-N2-isobutanoylguanine

Conditions
ConditionsYield
With ammonia In methanol at 25 - 28℃; for 10h;90%
2',3',5'-tri-O-acetyl-guanosine
6979-94-8

2',3',5'-tri-O-acetyl-guanosine

Conditions
ConditionsYield
With methanol; water; triethylamine at 71℃; Microwave irradiation;89%
2-bromo-9-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)hypoxanthine
41623-91-0

2-bromo-9-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)hypoxanthine

Conditions
ConditionsYield
With ammonia In methanol at 120℃;80%
With ammonium hydroxide at 150℃; for 3h;48%
Acetic acid (2R,3R,4R,5R)-4-acetoxy-5-acetoxymethyl-2-(6-diphenylcarbamoyloxy-2-isobutyrylamino-purin-9-yl)-tetrahydro-furan-3-yl ester

Acetic acid (2R,3R,4R,5R)-4-acetoxy-5-acetoxymethyl-2-(6-diphenylcarbamoyloxy-2-isobutyrylamino-purin-9-yl)-tetrahydro-furan-3-yl ester

Conditions
ConditionsYield
With methanol; ammonia for 24h; Ambient temperature;80%
2-(acetylamino)-6-(diphenylcarbamoyloxy)-9-(β-D-tri-O-acetylribofuranosyl)-9H-purine
112233-75-7

2-(acetylamino)-6-(diphenylcarbamoyloxy)-9-(β-D-tri-O-acetylribofuranosyl)-9H-purine

Conditions
ConditionsYield
With ammonia In methanol; water at 60℃;75%
With methanol; ammonia for 24h; Ambient temperature;75%
2',1''-anhydro-5-<(1''-benzamido-1''-hydroxymethylene)amino>-1-(β-D-ribofuranosyl)imidazole-4-carboxamide
58917-66-1

2',1''-anhydro-5-<(1''-benzamido-1''-hydroxymethylene)amino>-1-(β-D-ribofuranosyl)imidazole-4-carboxamide

B

[1-(15)N]guanosine

[1-(15)N]guanosine

C

<15NH2>guanosine
103654-70-2

<15NH2>guanosine

Conditions
ConditionsYield
With (15N)-ammonium chloride In dimethyl sulfoxide at 100℃; for 240h; Yields of byproduct given;A n/a
B 75%
C n/a
With (15N)-ammonium chloride In dimethyl sulfoxide at 100℃; for 240h; Yield given. Yields of byproduct given;
8-mercaptoguanosine
26001-38-7

8-mercaptoguanosine

Conditions
ConditionsYield
With potassium bromide In water at 20℃; pH=7; Reagent/catalyst; Inert atmosphere; Irradiation;57.4%
Multi-step reaction with 3 steps
1: dihydrogen peroxide; acetic acid / 48 h / 65 °C
2: lithium hydroxide; water-d2 / Sonication
3: 24 h / 50 °C
View Scheme
1-(β-D-ribofuranosyl)-5-(thiocarbamoyl)amino-1H-imidazole-4-carboxamide
133068-54-9

1-(β-D-ribofuranosyl)-5-(thiocarbamoyl)amino-1H-imidazole-4-carboxamide

Conditions
ConditionsYield
With sodium hydroxide; copper diacetate for 1.5h; Heating;53%
2-Chloroadenosine
146-77-0

2-Chloroadenosine

Conditions
ConditionsYield
With acetic acid; sodium nitrite anschl. Erhitzen mit aethanol. NH3;
α-D-ribofuranosyl-1-phosphate
18646-11-2

α-D-ribofuranosyl-1-phosphate

guanine
73-40-5

guanine

Conditions
ConditionsYield
bei der Einwirkung von Purinnucleosid-Phosphorylase;
Acetic acid (2R,3R,4R,5R)-4-acetoxy-5-acetoxymethyl-2-(2-acetylamino-6-oxo-1,6-dihydro-purin-9-yl)-tetrahydro-furan-3-yl ester
30747-23-0

Acetic acid (2R,3R,4R,5R)-4-acetoxy-5-acetoxymethyl-2-(2-acetylamino-6-oxo-1,6-dihydro-purin-9-yl)-tetrahydro-furan-3-yl ester

Conditions
ConditionsYield
With ammonia In methanol for 42h; Ambient temperature;
Multi-step reaction with 2 steps
1: 77 percent / EtN(i-Pr)2 / pyridine / 1 h / Ambient temperature
2: 75 percent / NH3/MeOH / 24 h / Ambient temperature
View Scheme
N2-acetyl-9-(2',3',5'-tri-O-benzoyl-β-D-ribofuranosyl)guanine
17494-84-7

N2-acetyl-9-(2',3',5'-tri-O-benzoyl-β-D-ribofuranosyl)guanine

Conditions
ConditionsYield
With ammonia In methanol for 42h; Ambient temperature;
2-amino-6-benzyloxy-9-β-D-ribofuranosylpurine
4552-61-8

2-amino-6-benzyloxy-9-β-D-ribofuranosylpurine

A

7-benzylguanosine
72360-76-0

7-benzylguanosine

B

8-benzylguanosine
88158-12-7

8-benzylguanosine

C

N2-benzyl-2'-deoxyguanosine
71171-58-9

N2-benzyl-2'-deoxyguanosine

Conditions
ConditionsYield
With hydrogen cation In methanol; water at 40℃; Rate constant; Mechanism; pH 3.5, MeOH/aqueous buffer (5:95); other pH;A 0.4 % Chromat.
B 0.5 % Chromat.
C 1.2 % Chromat.
D 97.9 % Chromat.
O6-(p-methylbenzyl)guanosine
79384-30-8

O6-(p-methylbenzyl)guanosine

A

1-(p-methylbenzyl)guanosine
88158-18-3

1-(p-methylbenzyl)guanosine

B

N2-(p-methylbenzyl)guanosine
79396-24-0

N2-(p-methylbenzyl)guanosine

C

8-(p-methylbenzyl)guanosine
88158-13-8

8-(p-methylbenzyl)guanosine

D

C18H21N5O5
104375-85-1

C18H21N5O5

Conditions
ConditionsYield
With hydrogen cation In methanol; water at 40℃; Rate constant; Mechanism; pH 3.5, MeOH/aqueous buffer (5:95); other pH;A 1.2 % Chromat.
B 3.9 % Chromat.
C 2.6 % Chromat.
D 2.9 % Chromat.
E 89.4 % Chromat.
O6-(p-chlorobenzyl)guanosine
88158-11-6

O6-(p-chlorobenzyl)guanosine

Conditions
ConditionsYield
With hydrogen cation In methanol; water at 40℃; for 336h; Rate constant; Mechanism; pH 3.5, MeOH/aqueous buffer (5:95); other pH;100 % Chromat.
O6-(p-methoxybenzyl)guanosine
78907-22-9

O6-(p-methoxybenzyl)guanosine

A

N2-(p-methoxybenzyl)guanosine
78907-25-2

N2-(p-methoxybenzyl)guanosine

B

1-(p-methoxybenzyl)guanosine
78907-27-4

1-(p-methoxybenzyl)guanosine

C

8-(p-methoxybenzyl)guanosine
78907-24-1

8-(p-methoxybenzyl)guanosine

D

7-(p-methoxybenzyl)guanosine
78907-23-0

7-(p-methoxybenzyl)guanosine

Conditions
ConditionsYield
With hydrogen cation In methanol; water at 40℃; Rate constant; Mechanism; pH 3.5, MeOH/aqueous buffer (5:95); other pH;A 21.5 % Chromat.
B 0.2 % Chromat.
C 0.4 % Chromat.
D 1.1 % Chromat.
E 76.8 % Chromat.
O6-(p-methoxybenzyl)guanosine
78907-22-9

O6-(p-methoxybenzyl)guanosine

A

N2-(p-methoxybenzyl)guanosine
78907-25-2

N2-(p-methoxybenzyl)guanosine

B

1-(p-methoxybenzyl)guanosine
78907-27-4

1-(p-methoxybenzyl)guanosine

C

8-(p-methoxybenzyl)guanosine
78907-24-1

8-(p-methoxybenzyl)guanosine

D

7-(p-methoxybenzyl)guanosine
78907-23-0

7-(p-methoxybenzyl)guanosine

E

4-(p-methoxybenzyl)-5-guanidino-1-β-D-ribofuranozylimidazole
78907-26-3

4-(p-methoxybenzyl)-5-guanidino-1-β-D-ribofuranozylimidazole

Conditions
ConditionsYield
In methanol; water at 40℃; Rate constant; approximate rate constants for formation of products;

A

cytidine 3'-monophosphate
84-52-6

cytidine 3'-monophosphate

Conditions
ConditionsYield
With ribonuclease A Product distribution; determination of structure;
2'-O-(4-methoxytetrahydropyran-4-yl)guanosine
69471-61-0

2'-O-(4-methoxytetrahydropyran-4-yl)guanosine

Conditions
ConditionsYield
With hydrogenchloride at 22℃; for 0.583333h; Kinetics;50 % Chromat.
3-(β-D-pentofuranosyl)pyrimido<1,2-a>purin-10(3H)-one
78880-62-3

3-(β-D-pentofuranosyl)pyrimido<1,2-a>purin-10(3H)-one

A

Malondialdehyde
542-78-9

Malondialdehyde

Conditions
ConditionsYield
With sodium hydroxide; water at 45℃;
8-amino-3,10-dihydro-10-oxo-3-β-D-ribofuranosyl-1,3,5-triazino<1,2-a>purine
92220-57-0

8-amino-3,10-dihydro-10-oxo-3-β-D-ribofuranosyl-1,3,5-triazino<1,2-a>purine

Conditions
ConditionsYield
With sodium hydroxide at 20℃; for 0.0833333h; Product distribution;
N2-<<9-fluorenylmethyl)oxy>carbonyl>guanosine
87424-18-8

N2-<<9-fluorenylmethyl)oxy>carbonyl>guanosine

Conditions
ConditionsYield
With ammonium hydroxide In pyridine at 20℃; for 0.5h;
cytidine guanosine base pair

cytidine guanosine base pair

B

CYTIDINE
65-46-3

CYTIDINE

Conditions
ConditionsYield
In methanol; dimethyl sulfoxide at -26.1 - 29.9℃; Equilibrium constant;
CpCpGp

CpCpGp

A

cytidine 3'-monophosphate
84-52-6

cytidine 3'-monophosphate

Conditions
ConditionsYield
With ribonuclease A Product distribution; determination of structure;
5'-guanosine monophosphate
85-32-5

5'-guanosine monophosphate

Conditions
ConditionsYield
With water at 30℃; for 0.166667h; Rate constant; relative rate, different alkaline phosphotases;
In water at 37℃; for 240h;
guanosine 2',3'-cyclic monophosphate
634-02-6

guanosine 2',3'-cyclic monophosphate

A

guanosine 3'-monophosphate
117-68-0

guanosine 3'-monophosphate

B

guanosine 2'-monophosphate
130-50-7

guanosine 2'-monophosphate

Conditions
ConditionsYield
With chicken plasma membrane protein In water at 30℃; for 2h; Product distribution; other temperatures;
C47H60N18O33P4
99519-21-8

C47H60N18O33P4

B

uridine
58-96-8

uridine

C

CYTIDINE
65-46-3

CYTIDINE

D

adenosine
58-61-7

adenosine

Conditions
ConditionsYield
With Croatalus Adamanteus snake venom phosphodiesterase; MgCl2,tris-hydrochloride buffer; monoesterase In water at 37℃; for 18h; Product distribution;
N,N-dimethyl-formamide dimethyl acetal
4637-24-5

N,N-dimethyl-formamide dimethyl acetal

N2-(dimethylaminomethylene)guanosine
17331-16-7

N2-(dimethylaminomethylene)guanosine

Conditions
ConditionsYield
In methanol Ambient temperature;100%
In methanol at 20℃; for 72h;99%
In methanol for 72h;99%
8-bromoguanosine
4016-63-1

8-bromoguanosine

Conditions
ConditionsYield
With bromine In water at 20℃;100%
With bromine In water at 20℃; for 24h;99%
With bromine In water93%
C12H13N7
406945-71-9

C12H13N7

1-(2-amino-9H-purin-6-yl)-4-dimethylamino-pyridinium; 2-amino-9-(3,4-dihydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-9H-purin-6-olate

1-(2-amino-9H-purin-6-yl)-4-dimethylamino-pyridinium; 2-amino-9-(3,4-dihydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-9H-purin-6-olate

Conditions
ConditionsYield
In water-d2100%
allyl bromide
106-95-6

allyl bromide

7-allyl-2-amino-1H-purine-6(7H)-one
21869-84-1

7-allyl-2-amino-1H-purine-6(7H)-one

Conditions
ConditionsYield
Stage #1: allyl bromide; G In dimethyl sulfoxide at 20℃; for 18h;
Stage #2: With hydrogenchloride; water In dimethyl sulfoxide for 0.75h;
Stage #3: With sodium hydroxide In methanol; water; dimethyl sulfoxide
100%
Stage #1: allyl bromide; G In dimethyl sulfoxide at 20℃; for 18h; Inert atmosphere;
Stage #2: With hydrogenchloride In water; dimethyl sulfoxide for 1h;
92.5%
In dimethyl sulfoxide at 20℃; for 24h; Concentration; Inert atmosphere; Large scale;58.7%
2,2-dimethoxy-propane
77-76-9

2,2-dimethoxy-propane

acetone
67-64-1

acetone

2',3'-isopropylideneguanosine
362-76-5

2',3'-isopropylideneguanosine

Conditions
ConditionsYield
With toluene-4-sulfonic acid at 20℃; for 72h; Inert atmosphere;100%
acetic anhydride
108-24-7

acetic anhydride

2',3',5'-tri-O-acetyl-guanosine
6979-94-8

2',3',5'-tri-O-acetyl-guanosine

Conditions
ConditionsYield
With dmap; triethylamine In acetonitrile at 0 - 20℃; for 4h;99%
With dmap; triethylamine In acetonitrile for 0.5h; Ambient temperature;98%
With dmap; triethylamine In acetonitrile Heating;98%
<8-2H>guanosine
96412-41-8

<8-2H>guanosine

Conditions
ConditionsYield
With hydrogen; water-d2; palladium on activated charcoal at 110℃; for 24h;99%
With water-d2 for 15h; Heating;92%
With water-d2; palladium on activated charcoal; hydrogen at 110℃; for 24h;92%
chloro(2,2':6',2''-terpyridine)platinum(II) chloride dihydrate

chloro(2,2':6',2''-terpyridine)platinum(II) chloride dihydrate

N(1),N(6)-bis[(2,2':6',2''-terpyridine)platinio(II)]guanosine

N(1),N(6)-bis[(2,2':6',2''-terpyridine)platinio(II)]guanosine

Conditions
ConditionsYield
With silver nitrate In water byproducts: AgCl; Pt-complex and Ag-salt soln. heating at 70-80°C for 2 h, AgCl centrifugation off, org. compd. soln. addn., soln. heating at 70°C for 2 h, centrifugation; soln. freeze drying;99%
2-Methylpropionic anhydride
97-72-3

2-Methylpropionic anhydride

N2-(2-methylpropanoyl)-2',3',5'-tris-O-(2-methylpropanoyl)guanosine
70337-80-3

N2-(2-methylpropanoyl)-2',3',5'-tris-O-(2-methylpropanoyl)guanosine

Conditions
ConditionsYield
In pyridine at 110℃; for 20h;98%
With dmap In pyridine at 50℃; for 24h;
5,6-dimethyl-1H-benzo[d]imida-zole
582-60-5

5,6-dimethyl-1H-benzo[d]imida-zole

(β-D-ribofuranosyl)-5,6-dimethylbenzimidazole
13082-84-3

(β-D-ribofuranosyl)-5,6-dimethylbenzimidazole

Conditions
ConditionsYield
for 1.5h; purine nucleoside phosphorylase of whole cells of E. coli BMT 1D/1A;98%
Phenoxyacetyl chloride
701-99-5

Phenoxyacetyl chloride

N2-(phenoxyacetyl)guanosine
119824-66-7

N2-(phenoxyacetyl)guanosine

Conditions
ConditionsYield
Stage #1: G With pyridine; chloro-trimethyl-silane In dichloromethane for 2h;
Stage #2: Phenoxyacetyl chloride In dichloromethane at 0℃; for 3h;
Stage #3: With methanol In dichloromethane at 20℃; for 12h;
98%
With pyridine; chloro-trimethyl-silane; benzotriazol-1-ol 1.) 45 min, 2.) acetonitrile, 55 deg C, 5 h; Yield given. Multistep reaction;
Stage #1: G With pyridine; chloro-trimethyl-silane In dichloromethane at 0 - 20℃; for 3h; Inert atmosphere;
Stage #2: Phenoxyacetyl chloride In dichloromethane for 3h; Cooling with ice;
150.2 g
2-amino-1,9-dihydro-6H-purin-6-one
73-40-5

2-amino-1,9-dihydro-6H-purin-6-one

Conditions
ConditionsYield
With sulfuric acid In water at 90℃; for 1.5h; Reagent/catalyst; Temperature; Solvent; Large scale;98%
With sodium dichromate In water at 24.85℃; Quantum yield; Further Variations:; Reagents; pH-values; Decomposition; Photolysis;
With Lupinus luteus guanosine-inosine nucleosidase Enzyme kinetics;
acetone
67-64-1

acetone

2',3'-isopropylideneguanosine
362-76-5

2',3'-isopropylideneguanosine

Conditions
ConditionsYield
With perchloric acid at 20℃; for 1.16667h;98%
With perchloric acid In water at 20℃; for 4h;94%
Stage #1: G; acetone With perchloric acid at 20℃; for 1.16667h;
Stage #2: With ammonia In water at 0℃;
92%
acetyl chloride
75-36-5

acetyl chloride

N2-acetylguanosine
129681-72-7, 21967-06-6

N2-acetylguanosine

Conditions
ConditionsYield
Stage #1: G With pyridine; chloro-trimethyl-silane In dichloromethane for 2h;
Stage #2: acetyl chloride In dichloromethane at 0℃; for 1.5h;
Stage #3: With methanol In dichloromethane at 20℃; for 12h;
98%
(diethylenetriamino)copper(II) nitrate

(diethylenetriamino)copper(II) nitrate

sodium nicotinate
54-86-4

sodium nicotinate

water
7732-18-5

water

[Cu(diethylenetriamine)(nicotinic acid-H)(N7-guanosine)(NO3)]*5H2O

[Cu(diethylenetriamine)(nicotinic acid-H)(N7-guanosine)(NO3)]*5H2O

Conditions
ConditionsYield
In methanol; ethanol; water soln. of sodium nicotinate (5 mmol) in H2O/EtOH (1/10 v/v) added dropwise to soln. of Cu complex (5 mmol) in H2O/MeOH (1/10 v/v); stirred (5 min); guanosine (5 mmol) in EtOH added; stirred (12 h); solid isolated by filtration; washed with Et2O; dried (room temp.); elem. anal.;98%
ethyl iodide
75-03-6

ethyl iodide

7-ethylguanine hydrochloride

7-ethylguanine hydrochloride

Conditions
ConditionsYield
Stage #1: ethyl iodide; G In N,N-dimethyl acetamide at 20℃; for 24h;
Stage #2: With hydrogenchloride for 1.5h; Heating;
97%
propionic acid anhydride
123-62-6

propionic acid anhydride

2',3',5'-tri-O-propionyl-N2-propionylguanosine
90742-12-4

2',3',5'-tri-O-propionyl-N2-propionylguanosine

Conditions
ConditionsYield
With dmap In pyridine at 70℃; for 3h;96%
dimethyl sulfate
77-78-1

dimethyl sulfate

7-methylguanine hydrochloride

7-methylguanine hydrochloride

Conditions
ConditionsYield
Stage #1: G; dimethyl sulfate In N,N-dimethyl acetamide at 20℃; for 6h;
Stage #2: With hydrogenchloride for 1.5h; Heating;
96%
acetic anhydride
108-24-7

acetic anhydride

A

2,9-diacetylguanine
3056-33-5

2,9-diacetylguanine

B

1,2,3,5-tetraacetylribose
13035-61-5

1,2,3,5-tetraacetylribose

Conditions
ConditionsYield
Stage #1: acetic anhydride; G at 136℃; for 1h;
Stage #2: With trifluoroacetic acid at 60 - 100℃;
A 96%
B 86%
acetic anhydride
108-24-7

acetic anhydride

2-amino-6-hydroxyl-9-(2',3',5'-tri-O-acetyl-β-D-ribofuranosyl)purine
6979-94-8

2-amino-6-hydroxyl-9-(2',3',5'-tri-O-acetyl-β-D-ribofuranosyl)purine

Conditions
ConditionsYield
With dmap; triethylamine In acetonitrile at 20℃; for 0.5h;96%
With dmap; triethylamine In acetonitrile at 20℃; for 0.666667h;96%
tert-butyldimethylsilyl chloride
18162-48-6

tert-butyldimethylsilyl chloride

5'-O-tert-butyldimethylsilylguanosine
72409-21-3

5'-O-tert-butyldimethylsilylguanosine

Conditions
ConditionsYield
With silver nitrate In tetrahydrofuran for 3h; Ambient temperature;95%
silver nitrate In tetrahydrofuran for 1h;95%
With dmap; triethylamine In dichloromethane; dimethyl sulfoxide at 20℃; for 24h; Inert atmosphere;87%
1,3-Dichloro-1,1,3,3-tetraisopropyldisiloxane
69304-37-6

1,3-Dichloro-1,1,3,3-tetraisopropyldisiloxane

3',5'-O-1,1,3,3-tetraisopropyldisiloxan-1,3-diyl-guanosine
69304-44-5

3',5'-O-1,1,3,3-tetraisopropyldisiloxan-1,3-diyl-guanosine

Conditions
ConditionsYield
With 1H-imidazole In N,N-dimethyl-formamide for 0.75h; Ambient temperature;95%
With 1H-imidazole In pyridine; N,N-dimethyl-formamide for 4h;93%
With 1H-imidazole In N,N-dimethyl-formamide at 20℃; for 16h; Inert atmosphere; Large scale;92%
di-tert-butylsilyl bis(trifluoromethanesulfonate)
85272-31-7

di-tert-butylsilyl bis(trifluoromethanesulfonate)

2-amino-9-((4aR,6R,7R,7aS)-2,2-di-tert-butyl-7-hydroxytetrahydro-4H-furo[3,2-d][1,3,2]dioxasilin-6-yl)-1,9-dihydro-6H-purin-6-one
126628-29-3

2-amino-9-((4aR,6R,7R,7aS)-2,2-di-tert-butyl-7-hydroxytetrahydro-4H-furo[3,2-d][1,3,2]dioxasilin-6-yl)-1,9-dihydro-6H-purin-6-one

Conditions
ConditionsYield
In N,N-dimethyl-formamide95%
With 2,6-dimethylpyridine In N,N-dimethyl-formamide at 0 - 20℃; for 1h; Inert atmosphere;95%
In N,N-dimethyl-formamide at 0℃; Inert atmosphere;89%
N,N-dimethyl-formamide dimethyl acetal
4637-24-5

N,N-dimethyl-formamide dimethyl acetal

N2-[(dimethylamino)methylene]guanosine
1055407-32-3

N2-[(dimethylamino)methylene]guanosine

Conditions
ConditionsYield
In methanol at 27℃; for 96h;95%
oxirane
75-21-8

oxirane

7-(2'-hydroxyethyl)guanine hydrochloride

7-(2'-hydroxyethyl)guanine hydrochloride

Conditions
ConditionsYield
Stage #1: oxirane; G With acetic acid at 100℃; for 0.5h;
Stage #2: With hydrogenchloride for 1.5h; Heating;
95%
palladium diacetate
3375-31-3

palladium diacetate

Pd(2+)*CH3COO(1-)*C10H12N5O5(1-)*3H2O=[Pd(CH3COO)(C10H12N5O5)]*3H2O

Pd(2+)*CH3COO(1-)*C10H12N5O5(1-)*3H2O=[Pd(CH3COO)(C10H12N5O5)]*3H2O

Conditions
ConditionsYield
In water; acetone stirring (hot soln., 3 h), pptn.; centrifugation, washing (water, acetone), drying (air); elem. anal.;95%
ethyl iodide
75-03-6

ethyl iodide

7-ethylguanine

7-ethylguanine

Conditions
ConditionsYield
Stage #1: ethyl iodide; G In N,N-dimethyl acetamide at 60℃; Inert atmosphere;
Stage #2: With hydrogenchloride In N,N-dimethyl acetamide; water at 110℃; for 1h;
Stage #3: With ammonia In N,N-dimethyl acetamide; water at 20℃;
95%
Stage #1: ethyl iodide; G In N,N-dimethyl acetamide at 60℃; Inert atmosphere;
Stage #2: With hydrogenchloride In N,N-dimethyl acetamide; water at 110℃; for 1h;
95%

118-00-3Related news

Guanosine (cas 118-00-3) protects against Ca2+-induced mitochondrial dysfunction in rats09/03/2019

Mitochondria play an important role in cell life and in the regulation of cell death. In addition, mitochondrial dysfunction contributes to a wide range of neuropathologies. The nucleoside Guanosine (GUO) is an endogenous molecule, presenting antioxidant properties, possibly due to its direct sc...detailed

Elevated plasma cyclic Guanosine (cas 118-00-3) monophosphate may explain greater efferent arteriolar tone in adults with longstanding type 1 diabetes: A brief report☆09/02/2019

Cyclic guanosine monophosphate (cGMP) influences intrarenal hemodynamics in animal models, but the relationship between cGMP and renal function in adults with type 1 diabetes (T1D) remains unclear. In this study, plasma cGMP correlated with efferent arteriolar resistance, effective renal plasma ...detailed

Guanosine (cas 118-00-3) exerts antiplatelet and antithrombotic properties through an adenosine-related cAMP-PKA signaling08/30/2019

BackgroundGuanosine is a natural product and an endogenous nucleoside that has shown to increase during myocardial ischemia. Platelets are critically involved in ischemic coronary events. It remains unknown, however, whether guanosine may affect platelet activation and function. We sought to inv...detailed

Augmentation effect of ketamine by Guanosine (cas 118-00-3) in the novelty-suppressed feeding test is dependent on mTOR signaling pathway08/26/2019

The ketamine's potential for the treatment of refractory depression and anxiety has been considered one the most important discoveries in the last years, however, repeated use of ketamine is limited due to its side/adverse effects. Therefore, the search for effective augmentation strategies...detailed

118-00-3Relevant articles and documents

Simple method for fast deprotection of nucleosides by triethylamine- catalyzed methanolysis of acetates in aqueous medium

Meier, Lidiane,Monteiro, Gustavo C.,Baldissera, Rodrigo A.M.,Sa?, Marcus Mandolesi

, p. 859 - 866 (2010)

A straightforward methodology for deacetylation of protected ribonucleosides was developed based on triethylamine-catalyzed solvolysis in aqueous methanol. Reactions are completed in a few minutes under microwave irradiation and the free nucleosides are obtained in high yield after simple evaporation of volatiles. Other important features include the involvement of readily available reagents and the compatibility with diverse functional groups, which make this process very attractive for broad application.

N,N-Dibenzyl formamidine as a new protective group for primary amines

Vincent, Stephane,Mons, Stephane,Lebeau, Luc,Mioskowski, Charles

, p. 7527 - 7530 (1997)

Primary amines can be converted in high yield into N,N-dibenzyl formamidines under mild conditions. The N,N-dibenzyl formamidine group was found to be effective as a protective group for primary amines as it is stable to a variety of conditions and can be removed by catalytic hydrogenation.

THE PROTECTION OF 2'-HYDROXY FUNCTIONS IN OLIGORIBONUCLEOTIDE SYNTHESIS

Norman, G. David,Reese, B. Colin,Serafinowska, T. Halina

, p. 3015 - 3018 (1984)

The suitability of the 4-methoxytetrahydropyran-4-yl group for the protection of 2' ( or 3')-hydroxy functions in oligoribonucleotide synthesis is confirmed; the latter protecting group is removed in 0.01M-hydrochloric acid at room temperature under conditions which, contrary to a recent report, lead to no detectable cleavage or migration of the internucleotide phosphodiester linkages.

Chemical radiation studies of 8-bromoguanosine in aqueous solutions

Ioele, Marcella,Bazzanini, Rita,Chatgilialoglu, Chryssostomos,Mulazzani, Quinto G.

, p. 1900 - 1907 (2000)

Chemical radiolytic methods were used to investigate the reactions of hydrated electrons (eaq-) with 8-bromoguanosine (8-Br-Guo) as a function of pH. γ-Radiolysis of 8-Br-Guo in aqueous solutions followed by product studies showed the formation of guanosine (Guo) as a single product at various pH. In D2O solutions the quantitative incorporation of deuterium at the 8-position was also observed. Pulse radiolysis revealed the instantaneous formation of a guanosine radical cation (Guo.+ or its deprotonated forms) in acid or basic solutions. The same transient species results from the reaction of H. with 8-Br-Guo at pH 3, as well as from the reaction of (CH3)2CO.- with 8-Br-Guo at pH 13. In neutral solution, the initial electron adduct was rapidly protonated to give the first observable transient species that decays by first-order kinetics (k = 5 × 104 s-1) to produce the Guo(-H+). radical once again. Tailored experiments allowed the reaction mechanism to be defined in some detail.

Hydrolytic reactions of guanosyl-(3′,3′)-uridine and guanosyl-(3′,3′)-(2′,5′-di-O-methyluridine)

Kiviniemi, Anu,Loennberg, Tuomas,Ora, Mikko

, p. 11040 - 11045 (2004)

Hydrolytic reactions of guanosyl-(3′,3′)-uridine and guanosyl-(3′,3′)-(2′,5′-di-O-methyluridine) have been followed by RP HPLC over a wide pH range at 363.2 K in order to elucidate the role of the 2′-hydroxyl group as a hydrogen-bond donor upon departure of the 3′-uridine moiety. Under neutral and basic conditions, guanosyl-(3′,3′)-uridine undergoes hydroxide ion-catalyzed cleavage (first order in [OH-]) of the P-O3′ bonds, giving uridine and guanosine 2′,3′-cyclic monophosphates, which are subsequently hydrolyzed to a mixture of 2′- and 3′-monophosphates. This bond rupture is 23 times as fast as the corresponding cleavage of the P-O3′ bond of guanosyl-(3′,3′)-(2,5′-di-O-methyluridine) to yield 2′,5′-O-dimethyluridine and guanosine 2′,3′-cyclic phosphate. Under acidic conditions, where the reactivity differences are smaller, depurination and isomerization compete with the cleavage. The effect of Zn2+ on the cleavage of the P-O3′ bonds of guanosyl-(3′,3′)-uridine is modest: about 6-fold acceleration was observed at [Zn2+] = 5 mmol L-1 and pH 5.6. With guanosyl-(3′,3′)-(2′,5′-di-O-methyluridine) the rate-acceleration effect is greater: a 37-fold acceleration was observed. The mechanisms of the partial reactions, in particular the effects of the 2′-hydroxyl group on the departure of the 3′-linked nucleoside, are discussed.

-

Uchida,Makino

, p. 1 (1953)

-

1,1,1,3,3,3-Hexafluoro-2-propanol for the Removal of the 4,4'-Dimethoxytrityl Protecting Group from the 5'-Hydroxyl of Acid-Sensitive Nucleosides and Nucleotides

Leonard, Nelson J.,Neelima

, p. 7833 - 7836 (1995)

1,1,1,3,3,3-Hexafluoro-2-propanol is introduced as a suitable reagent and solvent for the detritylation of 5'-O-(4,4'-dimethoxytrityl)-nucleosides and -deoxy- nucleosides, especially those that are susceptible to N-glycosyl cleavage under more strongly acidic conditions.

Synthesis of 2'-O-methoxyethylguanosine using a novel silicon-based protecting group.

Wen,Chow, Suetying,Sanghvi, Yogesh S,Theodorakis, Emmanuel A

, p. 7887 - 7889 (2002)

A short and efficient synthesis of 2'-O-methoxyethylguanosine (8) is described. Central to this strategy is the development of a novel silicon-based protecting group (MDPSCl(2), 2) used to protect the 3',5'-hydroxyl groups of the ribose. Silylation of guanosine with 2 proceeded with excellent regioselectivity and in 79% yield. Alkylation of the 2'-hydroxyl group of 6 proceeded with methoxyethyl bromide and NaHMDS and afforded compound 7 in 85% yield, without any noticeable cleavage of the silyl protecting group and without the need to protect the guanine base moiety. Finally, deprotection of 7 was achieved using TBAF and produced 8 in 97% yield.

An efficient approach for conversion of 5-substituted 2-thiouridines built in RNA oligomers into corresponding desulfured 4-pyrimidinone products

Chwialkowska, Anna,Wielgus, Ewelina,Leszczynska, Grazyna,Sobczak, Milena,Mikolajczyk, Barbara,Sochacka, Elzbieta,Nawrot, Barbara

, p. 3100 - 3104 (2015)

Abstract An efficient approach for the desulfuration of C5-substituted 2-thiouridines (R5S2U) bound in the RNA chain exclusively to 4-pyrimidinone nucleoside (R5H2U)-containing RNA products is proposed. This post-synthetic transformation avoids the preparation of a suitably protected H2U phosphoramidite, which otherwise would be necessary for solid-phase synthesis of the modified RNA. Optimization of the desulfuration, which included reaction stoichiometry, time and temperature, allowed to transform a set of ten R5S2U-RNAs into their R5H2U-RNA congeners in ca. 90% yield.

Watson-Crick Base Pairing between Guanosine and Cytidine Studied by 13C Nuclear Magnetic Resonance Spectroscopy

Petersen, Steffen B.,Led, Jens J.

, p. 5308 - 5313 (1981)

Watson-Crick base pairing in dimethyl sulfoxide/methanol (2/1 v/v) between the nucleosides guanosine and cytidine has been studied by carbon -13 nuclear magnetic resonance (13C NMR) spectroscopy at 67.89 MHz.The equilibrium constant for the base pairing complex has been obtained at two different temperatures by a nonlinear least-squares analysis of the experimental shift data for the base carbons, and the enthalpy of interaction has been found to be ca. -3.8 kcal/mol.The analysis furthermore indicates that while base pairing and changes in the syn/anti conformation ratio are independent processes in the case of guanosine, a change from syn to anti conformation occurs simultaneously with the base pairing in the case of cytidine, in agreement with the Watson-Crick base pairing model.As inferred from the results base pairing alters the polarizabilities of the nucleosides.

Biocatalytic separation of N -7/ N -9 guanine nucleosides

Singh, Sunil K.,Sharma, Vivek K.,Olsen, Carl E.,Wengel, Jesper,Parmar, Virinder S.,Prasad, Ashok K.

, p. 7932 - 7935 (2010)

Vorbrueggen coupling of trimethylsilylated 2-N-isobutanoylguanine with peracetylated pentofuranose derivatives generally gives inseparable N-7/N-9 glycosyl mixtures. We have shown that the two isomers can be separated biocatalytically by Novozyme-435-mediated selective deacetylation of the 5′-O-acetyl group of peracetylated N-9 guanine nucleosides.

-

Zemlicka,Chladek

, p. 715 (1969)

-

Dissociation of Platinum(II) Nucleobase Complexes - Evidence for a Three-path Mechanism via a Five-coordinate Intermediate

Mikola, Marjaana,Vihanto, Jouko,Arpalahti, Jorma

, p. 1759 - 1760 (1995)

In thiourea assisted dissociation of 2+ (Guo = guanosine, dien = diethylenetriamine) in aqueous solution (pH = ca. 3) the nucleophile dependent reaction follows a three-path mechanism, in which the initial binding of the nucleophile to the complex and the ring-opening step of the terdentate dien ligand are reversible.

STRUCTURE OF A NEW MODIFIED NUCLEOSIDE FORMED BY GUANOSINE-MALONALDEHYDE REACTION

Seto, Hiroshi,Akiyama, Kazuyuki,Okuda, Taisuke,Hashimoto, Tsuyoshi,Takesue, Tomoyuki,Ikemura, Tadashi

, p. 707 - 708 (1981)

A new modified nucleoside was formed by the reaction of guanosine with malonaldehyde under acidic condition.This compound emitted strong yellow fluorescence and was hydrolyzed by NaOH into guanosine and malonaldehyde.Its structure was determined to be 1,N2-(1-propenyl-3-ylidene)guanosine by the spectroscopic analysis.

Kinetic properties of Cellulomonas sp. purine nucleoside phosphorylase with typical and non-typical substrates: Implications for the reaction mechanism

Wielgus-Kutrowska, Beata,Bzowska, Agnieszka

, p. 471 - 476 (2005)

Phosphorolysis catalyzed by Cellulomonas sp. PNP with typical nucleoside substrate, inosine (Ino), and non-typical 7-methylguanosine (m7Guo), with either nucleoside or phosphate (Pi) as the varied substrate, kinetics of the reverse synthetic reaction with guanine (Gua) and ribose-1-phosphate (R1P) as the varied substrates, and product inhibition patterns of synthetic and phosphorolytic reaction pathways were studied by steady-state kinetic methods. It is concluded that, like for mammalian trimeric PNP, complex kinetic characteristics observed for Cellulomonas enzyme results from simultaneous occurrence of three phenomena. These are sequential but random, not ordered binding of substrates, tight binding of me substrate purine bases, leading to the circumstances that for such substrates (products) rapid-equilibrium assumptions do not hold, and a dual role of Pi, a substrate, and also a reaction modifier that helps to release a tightly bound purine base. Copyright Taylor & Francis, Inc.

How easily oxidizable is DNA? One-electron reduction potentials of adenosine and guanosine radicals in aqueous solution

Steenken,Jovanovic

, p. 617 - 618 (1997)

-

Thermodynamic Reaction Control of Nucleoside Phosphorolysis

Kaspar, Felix,Giessmann, Robert T.,Neubauer, Peter,Wagner, Anke,Gimpel, Matthias

supporting information, p. 867 - 876 (2020/01/24)

Nucleoside analogs represent a class of important drugs for cancer and antiviral treatments. Nucleoside phosphorylases (NPases) catalyze the phosphorolysis of nucleosides and are widely employed for the synthesis of pentose-1-phosphates and nucleoside analogs, which are difficult to access via conventional synthetic methods. However, for the vast majority of nucleosides, it has been observed that either no or incomplete conversion of the starting materials is achieved in NPase-catalyzed reactions. For some substrates, it has been shown that these reactions are reversible equilibrium reactions that adhere to the law of mass action. In this contribution, we broadly demonstrate that nucleoside phosphorolysis is a thermodynamically controlled endothermic reaction that proceeds to a reaction equilibrium dictated by the substrate-specific equilibrium constant of phosphorolysis, irrespective of the type or amount of NPase used, as shown by several examples. Furthermore, we explored the temperature-dependency of nucleoside phosphorolysis equilibrium states and provide the apparent transformed reaction enthalpy and apparent transformed reaction entropy for 24 nucleosides, confirming that these conversions are thermodynamically controlled endothermic reactions. This data allows calculation of the Gibbs free energy and, consequently, the equilibrium constant of phosphorolysis at any given reaction temperature. Overall, our investigations revealed that pyrimidine nucleosides are generally more susceptible to phosphorolysis than purine nucleosides. The data disclosed in this work allow the accurate prediction of phosphorolysis or transglycosylation yields for a range of pyrimidine and purine nucleosides and thus serve to empower further research in the field of nucleoside biocatalysis. (Figure presented.).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 118-00-3